Menu
Search
|

Menu

Close
X

Zhejiang Jiuzhou Pharmaceutical Co Ltd 603456.SS (Shanghai Stock Exchange)

6.42 CNY
+0.02 (+0.31%)
As of Sep 21
chart
Previous Close 6.40
Open 6.38
Volume 1,609,800
3m Avg Volume 6,287,468
Today’s High 6.44
Today’s Low 6.35
52 Week High 11.69
52 Week Low 6.26
Shares Outstanding (mil) 805.96
Market Capitalization (mil) 5,158.15
Forward P/E 31.59
Dividend (Yield %) 0.11 ( 1.74 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.00 Mean rating from 2 analysts

KEY STATS

Revenue (mm, CNY)
FY18
920
FY17
1,717
FY16
1,653
FY15
1,445
EPS (CNY)
FY18
0.110
FY17
0.185
FY16
0.140
FY15
0.267
*Note: Units in Millions of Renminbi
**Note: Units in Renminbi

KEY RATIOS

Price to Earnings (TTM)
vs sector
31.59
32.69
Price to Sales (TTM)
vs sector
2.81
6.46
Price to Book (MRQ)
vs sector
1.92
3.90
Price to Cash Flow (TTM)
vs sector
--
23.20
Total Debt to Equity (MRQ)
vs sector
6.80
14.06
LT Debt to Equity (MRQ)
vs sector
0.00
11.24
Return on Investment (TTM)
vs sector
6.02
12.72
Return on Equity (TTM)
vs sector
6.18
14.85

EXECUTIVE LEADERSHIP

Lirong Hua
Chairman of the Board, Since 2016
Salary: --
Bonus: --
Zhihong Chen
General Manager, Since 2016
Salary: --
Bonus: --
Huilu Lin
Deputy General Manager, Secretary of the Board, Since
Salary: --
Bonus: --
Daqing Che
Deputy General Manager, Since
Salary: --
Bonus: --
Zulin Jiang
Deputy General Manager, Since
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

No.99, Waisha Road, Jiaojiang Di
TAIZHOU   ZHJ   318000

Phone: +86576.88706789

Zhejiang Jiuzhou Pharmaceutical Co.,Ltd. is a China-based company principally engaged in the research, development, production and sale of Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates. The Company mainly operates through two segments, including the Proprietary APIs and Intermediates Contract Development and Manufacturing Organization (CDMO) segment and the Specialty APIs and Intermediates segment. The Proprietary APIs and Intermediates CDMO segment mainly provides one-stop services for innovative medicines of pre-clinical chemical manufacturing and controls (CMC), clinical phases I, II and III, new drug application (NDA) and various stages after going public. The Specialty APIs and Intermediates segments mainly provides generic drug manufacturers with commercialized production services of APIs and their intermediates that expire or are about to expire.

SPONSORED STORIES